“…Decreased CI activity in the skeletal muscle or fibroblasts was confirmed in seven patients ( Herzer et al, 2010 ; Janssen et al, 2009 ; Koene et al, 2012 ), which is expected as NDUFAF2 has been implicated in both CI assembly ( Adjobo-Hermans et al, 2020 ; Guerrero-Castillo et al, 2017 ; Ogilvie et al, 2005 ; Vogel et al, 2007 ) and activity ( Schlehe et al, 2013 ). In 11 out of the 12 cases, the loss of NDUFAF2 was due to homozygous or hemizygous mutations that lead to the termination of NDUFAF2 synthesis [resulting in the variations: M1L, W3X, Y38X, W74X, I35SfsX17, A73GfsX5, R45X], or homozygous deletions in the NDUFAF2 gene / 450 kb deletion of a region including the NDUFAF2 gene ( Barghuti et al, 2008 ; Calvo et al, 2010 ; Fassone and Rahman, 2012 ; Ghaloul-Gonzalez et al, 2016 ; Herzer et al, 2010 ; Hoefs et al, 2009 ; Janssen et al, 2009 ; Koene et al, 2012 ; Ogilvie et al, 2005 ).…”